BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17909793)

  • 1. Semiautomatic volume of interest drawing for (18)F-FDG image analysis-method and preliminary results.
    Green AJ; Francis RJ; Baig S; Begent RH
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):393-406. PubMed ID: 17909793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.
    Musiek ES; Saboury B; Mishra S; Chen Y; Reddin JS; Newberg AB; Udupa JK; Detre JA; Hofheinz F; Torigian D; Alavi A
    Hell J Nucl Med; 2012; 15(3):190-6. PubMed ID: 23106049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET-based differential uptake volume histograms: a possible approach towards definition of biological target volumes.
    Devic S; Mohammed H; Tomic N; Aldelaijan S; De Blois F; Seuntjens J; Lehnert S; Faria S
    Br J Radiol; 2016 Jun; 89(1062):20150388. PubMed ID: 27007269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology.
    Cheebsumon P; Yaqub M; van Velden FH; Hoekstra OS; Lammertsma AA; Boellaard R
    Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2136-44. PubMed ID: 21858528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
    Van Weehaeghe D; Ceccarini J; Delva A; Robberecht W; Van Damme P; Van Laere K
    J Nucl Med; 2016 Aug; 57(8):1238-43. PubMed ID: 26940764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of tumour response with (18)F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax--a phantom study.
    Boucek JA; Francis RJ; Jones CG; Khan N; Turlach BA; Green AJ
    Phys Med Biol; 2008 Aug; 53(16):4213-30. PubMed ID: 18653927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients.
    Day E; Betler J; Parda D; Reitz B; Kirichenko A; Mohammadi S; Miften M
    Med Phys; 2009 Oct; 36(10):4349-58. PubMed ID: 19928065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
    Im HJ; Paeng JC; Cheon GJ; Kim EE; Lee JS; Goo JM; Kang KW; Chung JK; Lee DS
    Nucl Med Commun; 2016 Jun; 37(6):616-22. PubMed ID: 26836629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining multiple FDG-PET radiotherapy target segmentation methods to reduce the effect of variable performance of individual segmentation methods.
    McGurk RJ; Bowsher J; Lee JA; Das SK
    Med Phys; 2013 Apr; 40(4):042501. PubMed ID: 23556917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT.
    Skretting A; Evensen JF; Løndalen AM; Bogsrud TV; Glomset OK; Eilertsen K
    Acta Oncol; 2013 Apr; 52(3):636-44. PubMed ID: 23075421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
    Stahl A; Ott K; Schwaiger M; Weber WA
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1471-8. PubMed ID: 15257418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.
    Necib H; Garcia C; Wagner A; Vanderlinden B; Emonts P; Hendlisz A; Flamen P; Buvat I
    J Nucl Med; 2011 Mar; 52(3):354-61. PubMed ID: 21345787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An algorithm for PET tumor volume and activity quantification: without specifying camera's point spread function (PSF).
    Bhatt R; Adjouadi M; Goryawala M; Gulec SA; McGoron AJ
    Med Phys; 2012 Jul; 39(7):4187-202. PubMed ID: 22830752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation.
    Yamane T; Ikari Y; Nishio T; Ishii K; Ishii K; Kato T; Ito K; Silverman DH; Senda M; Asada T; Arai H; Sugishita M; Iwatsubo T;
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):244-9. PubMed ID: 23907243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?
    Basu S; Alavi A
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1527-9. PubMed ID: 17522857
    [No Abstract]   [Full Text] [Related]  

  • 16. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
    Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
    Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection of epileptic foci.
    Muzik O; Pourabdollah S; Juhasz C; Chugani DC; Janisse J; Draghici S
    IEEE Trans Biomed Eng; 2005 Sep; 52(9):1574-81. PubMed ID: 16189970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models.
    Vauclin S; Doyeux K; Hapdey S; Edet-Sanson A; Vera P; Gardin I
    Phys Med Biol; 2009 Nov; 54(22):6901-16. PubMed ID: 19864698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy.
    Ohta Y; Nariai T; Ishii K; Ishiwata K; Mishina M; Senda M; Hirakawa K; Ohno K
    Ann Nucl Med; 2008 Jul; 22(6):495-503. PubMed ID: 18670856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of fast-RAMLA in clinical PET.
    Sato H; Cho K; Fukushima Y; Shiiba M; Hakozaki K; Kiriyama T; Sakurai M; Kanaya K; Kumita S
    Ann Nucl Med; 2008 Dec; 22(10):869-76. PubMed ID: 19142705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.